CTT Pharmaceutical Holdings, Inc.'s Form 4 filing
CTT Pharmaceutical Holdings, Inc. (CTTH) · filed Oct 7, 2025
- Accession no.
- 0001035422-25-000014
- Filed
- Oct 7, 2025, 11:55 AM ET
- Trade date
- Sep 23, 2025
- Filing delay
- 14 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $408.9. It was filed 14 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| CTT Pharmaceutical Holdings, Inc.CIK 0001035422 | Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | CTTH | PPurchaseAcquired | +6,815 | $0.06 | +$408.9 | 7,767,756 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.